Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study

Overview of attention for article published in PLOS ONE, March 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs: 1 blog

patent: 1 patent

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Blogs Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Methods and compositions for prevention or treatment of a disease

Grant US-9574211-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.